Home
Conditions
Leukemia, Myeloid, Acute

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,461 public trials 543 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Not Yet Recruiting

Natural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid Leukemia

NCT05319249

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children

NCT06347458

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics

NCT06295029

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS

NCT06050941

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia Patients

NCT06252584

Conditions: Acute Myeloid Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Role of BMP Pathway in MDS Progression

NCT06175923

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Hospices Civils de Lyon Lyon, France

View Trial Details

Not Yet Recruiting

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

NCT06182592

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, High-risk (Secondary) Acute Myeloid Leukemia, +9 more
Locations: Institute of Hematology and Hospital of Blood Disease, Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Not Yet Recruiting

Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML

NCT06133556

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid Leukemia

NCT05944211

Conditions: Chemotherapy-Induced Thrombocytopenia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Impact of Allo-HSCT on Bone Remodeling: Evolution of Bone Mineral Density and Architecture Measured by Bone Densitometry

NCT05161026

Conditions: Bone Diseases, Bone Diseases, Metabolic, Hematologic Diseases, +11 more
Locations: Chu Amiens Amiens, France

CHU CAEN Caen, France

Chu Lille Lille, France

Chu Rouen Rouen, France

View Trial Details

Leukemia, Myeloid, Acute

Leukemia, Myeloid, Acute trial results

Related conditions